Cervical cancer is the second most common cause of death in women worldwide.
However, a new use for a common cancer drug is showing promise with helping some patients with stage four cancer live longer.
Avastin is already used to treat tumors in the colon, brain, kidneys and lungs and is now helping patients with advanced stage cervical cancer.
On average, women who received a combination of Avastin and chemotherapy lived nearly four months longer than women who received chemo alone.
While the drug increased the risk of some serious side effects, like blood clots and high-blood pressure, experts say it could become the standard for treating advanced stage cancers.